theheart.org ForumDiscussions among healthcare providers, clinicians, and researchers.
Visit the forum »
- FDA advisory panel votes in favor of broadened rosuvastatin indication
- First randomized study of endovascular aortic repair offers more questions, few answers
- Darusentan disappoints in DORADO-AC; company to drop the drug
- Mounting debate over aspirin use in primary prevention should prompt new talks with patients
- Low-carb diets hit the headlines again
- FDA panel readies to review expanded rosuvastatin label
- PROTECT halted: Event rates fall by treating HF with natriuretic-peptide guidance
- UK scientists unearth potential new biomarker for MI
- High-dose statin therapy reduces recurrent cardiovascular events
- Adverse lipid changes seen during transition to menopause
- Smoking promotes heart allograft rejection in rat study
- FDA advisory panel votes in favor of broadened rosuvastatin indication
- Mounting debate over aspirin use in primary prevention should prompt new talks with patients
- Intensive medical therapy in asymptomatic carotid stenosis helps reduce microemboli and CV risk
- Proposed device tax in health reform bill creates angst among device makers and cardiologists
- theheart.org blogger finally gets go-ahead for PCI without surgical backup
- Vitamin D: A potential role in cardiovascular disease prevention
- High-dose statin therapy reduces recurrent cardiovascular events
- FDA panel readies to review expanded rosuvastatin label
- UK diabetic cohort analysis confirms sulfonylurea risks, adds to glitazone debate
Click here to view news, discussions, and opinions relating to a specific conference- RSNA 2009 - Chicago, IL
- AHA 2009 - Orlando, FL
- OS 2009 - Washington, DC
- CCC 2009 - Edmonton, Canada
- IDF 2009 - Montreal, Canada






Drs. Hayes and Foody and a committee of experts address the gaps and correct the misconception that CVD is more common in men than women.




